causal
Surrogate Endpoints Speed Drug Development
A surrogate is a biomarker such as tumor shrinkage that predicts clinical benefit, and validated surrogates let developers decide to continue or discontinue a drug in years rather than waiting five to ten years for survival outcomes, which is why government agencies should invest heavily in finding them.
causalpending
Speaker
AlexEvidence Quote
“as soon as you have an established surrogate that the regulators can use, you really speed up how quickly you can iterate on developing drugs.”
Source
Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the BestCreated: 11/14/2026, 6:42:06 AM
Your notes
Loading notes...